Cargando…

8. Application of Pharmacogenetics in Dose Individualization in Diabetes, Psychiatry, Cancer and Cardiology

Detalles Bibliográficos
Autor principal:	Tomalik-Scharte, Dorota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Communications and Publications Division (CPD) of the IFCC 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975342/ https://www.ncbi.nlm.nih.gov/pubmed/27683291

Ejemplares similares

A Novel Toxicokinetic Modeling of Cypermethrin and Permethrin and Their Metabolites in Humans for Dose Reconstruction from Biomarker Data
por: Côté, Jonathan, et al.
Publicado: (2014)

Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
por: Tomalik-Scharte, Dorota, et al.
Publicado: (2010)

The Potential Utility of Pharmacogenetic Testing in Psychiatry
por: Gardner, Kathryn R., et al.
Publicado: (2014)

Pharmacogenetics in Psychiatry: An Update on Clinical Usability
por: van Schaik, Ron H. N., et al.
Publicado: (2020)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

“Black box” pharmacogenetic decision-support tools in psychiatry
por: Bousman, Chad A., et al.
Publicado: (2020)

Editorial: Precision psychiatry from a pharmacogenetics perspective
por: Brown, Lisa C., et al.
Publicado: (2023)

Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic
por: Claudio‐Campos, Karla, et al.
Publicado: (2020)

Pharmacogenetics in Psychiatry: Perceived Value and Opinions in a Chilean Sample of Practitioners
por: Undurraga, Juan, et al.
Publicado: (2021)

Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing
por: Yin, Anyue, et al.
Publicado: (2020)

Application of pharmacogenetics in oncology
por: Miteva-Marcheva, Nelly N., et al.
Publicado: (2020)

Systematic Review of Pharmacogenetic Warfarin Dosing
por: van Schie, Rianne M. F., et al.
Publicado: (2009)

Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals
por: Schipani, Alessandro, et al.
Publicado: (2011)

Upcoming Events in Pediatric Cardiology Pediatric Cardiology 41-8
Publicado: (2020)

Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics
por: Perwitasari, D. A., et al.
Publicado: (2011)

Cancer pharmacogenetics
por: Marsh, S, et al.
Publicado: (2004)

Pharmacogenetics of Anti-Diabetes Drugs
por: DiStefano, Johanna K., et al.
Publicado: (2010)

Vendor‐independent skin dose mapping application for interventional radiology and cardiology
por: Krajinović, Marko, et al.
Publicado: (2021)

6. Dose Adjustments Based on Pharmacogenetics of CYP450 Enzymes
por: van Schaik, Ron H.N.
Publicado: (2008)

Clinical Application of Pharmacogenetics: Where are We Now?
por: van Schaik, Ron HN
Publicado: (2014)

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
por: Hegyi, Marta, et al.
Publicado: (2016)

Machine Learning: An Overview and Applications in Pharmacogenetics
por: Cilluffo, Giovanna, et al.
Publicado: (2021)

Individualized immunosuppression in transplant patients: potential role of pharmacogenetics
por: Abboudi, Hamid, et al.
Publicado: (2012)

Patient Radiation Doses in Interventional Cardiology Procedures
por: Pantos, Ioannis, et al.
Publicado: (2009)

Occupational eye dose in interventional cardiology procedures
por: Haga, Yoshihiro, et al.
Publicado: (2017)

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
por: Jeiziner, Chiara, et al.
Publicado: (2022)

Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2018)

Implications of Inter-Individual Differences in Clopidogrel Metabolism, with Focus on Pharmacogenetics
por: Dahl, Marja-Liisa, et al.
Publicado: (2010)

Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
por: de Man, Femke M., et al.
Publicado: (2018)

Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database
por: Liu, Rong, et al.
Publicado: (2015)

Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients
por: Galvez, Jubby Marcela, et al.
Publicado: (2018)

The use of pharmacogenetics in clinical practice for the treatment of individuals with HIV infection in Thailand
por: Bushyakanist, Asalaysa, et al.
Publicado: (2015)

Applications of Machine Learning in Cardiology
por: Seetharam, Karthik, et al.
Publicado: (2022)

Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma
por: Goričar, Katja, et al.
Publicado: (2017)

Digital Health Applications for Pharmacogenetic Clinical Trials
por: Naik, Hetanshi, et al.
Publicado: (2020)

Pharmacogenetic guidance: individualized medicine promotes enhanced pain outcomes
por: Dragic, Lisa Lynn, et al.
Publicado: (2017)

Pharmacogenetics of immunosuppressant drugs: A new aspect for individualized therapy
por: Salvadori, Maurizio, et al.
Publicado: (2020)

Pharmacogenetics and Gender Association with Psychotic Episodes on Nortriptyline Lower Doses: Patient Cases
por: Piatkov, Irina, et al.
Publicado: (2011)

Warfarin Anticoagulant Therapy: A Southern Italy Pharmacogenetics-Based Dosing Model
por: Mazzaccara, Cristina, et al.
Publicado: (2013)

Establishment of a Han Chinese-specific pharmacogenetic-guided warfarin dosing algorithm
por: Pei, Lin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dja9o434oq00mi1t9p0qcn48np